Overview
Kentaro Yoshikawa practices practicing medicine in Toyama, Japan.
His clinical expertise encompasses Acute Myelomonocytic Leukemia.
He is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kentaro Yoshikawa
Is Kentaro Yoshikawa a top-rated expert for Acute Myelomonocytic Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Kentaro Yoshikawa is classified as an Experienced expert for Acute Myelomonocytic Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kentaro Yoshikawa participate in research or clinical trials?
Yes. Kentaro Yoshikawa has published 14 articles and abstracts on conditions like Acute Myelomonocytic Leukemia. You can view a list of Kentaro Yoshikawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Myelomonocytic LeukemiaMr. Yoshikawa isExperienced. Learn about Acute Myelomonocytic Leukemia.